Readystate Asset Management LP Purchases 48,962 Shares of Bath & Body Works, Inc. $BBWI

Readystate Asset Management LP grew its position in Bath & Body Works, Inc. (NYSE:BBWI) by 75.4% in the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 113,932 shares of the company’s stock after buying an additional 48,962 shares during the period. Readystate Asset Management LP owned approximately 0.06% of Bath & Body Works worth $2,635,000 at the end of the most recent quarter.

A number of other large investors have also made changes to their positions in BBWI. Parallel Advisors LLC lifted its holdings in Bath & Body Works by 42.6% during the fourth quarter. Parallel Advisors LLC now owns 1,897 shares of the company’s stock worth $38,000 after acquiring an additional 567 shares in the last quarter. State of Michigan Retirement System grew its stake in Bath & Body Works by 1.2% in the first quarter. State of Michigan Retirement System now owns 49,300 shares of the company’s stock valued at $920,000 after acquiring an additional 600 shares during the period. Meeder Asset Management Inc. increased its holdings in shares of Bath & Body Works by 28.5% in the fourth quarter. Meeder Asset Management Inc. now owns 2,874 shares of the company’s stock worth $58,000 after acquiring an additional 637 shares in the last quarter. State of Wyoming increased its holdings in shares of Bath & Body Works by 6.2% in the second quarter. State of Wyoming now owns 11,294 shares of the company’s stock worth $338,000 after acquiring an additional 661 shares in the last quarter. Finally, Vident Advisory LLC raised its position in shares of Bath & Body Works by 2.8% during the second quarter. Vident Advisory LLC now owns 25,229 shares of the company’s stock worth $756,000 after purchasing an additional 692 shares during the period. Institutional investors own 95.14% of the company’s stock.

Bath & Body Works Stock Performance

NYSE BBWI opened at $19.56 on Monday. Bath & Body Works, Inc. has a 52 week low of $14.27 and a 52 week high of $32.03. The stock’s 50 day moving average price is $20.06 and its two-hundred day moving average price is $19.80. The stock has a market capitalization of $3.94 billion, a price-to-earnings ratio of 5.09, a PEG ratio of 2.01 and a beta of 1.38.

Bath & Body Works (NYSE:BBWI) last issued its quarterly earnings results on Wednesday, August 26th. The company reported $0.62 earnings per share for the quarter, topping the consensus estimate of $0.24 by $0.38. Bath & Body Works had a net margin of 10.83% and a negative return on equity of 53.48%. The company had revenue of $1.51 billion during the quarter, compared to analysts’ expectations of $1.50 billion. During the same period last year, the business earned $0.30 EPS. The business’s quarterly revenue was down 2.3% on a year-over-year basis. Bath & Body Works has set its Q3 2026 guidance at 0.070-0.120 EPS and its FY 2026 guidance at 2.600-2.800 EPS. On average, equities research analysts forecast that Bath & Body Works, Inc. will post 2.73 EPS for the current year.

Bath & Body Works Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Friday, September 4th. Shareholders of record on Friday, August 21st were given a dividend of $0.20 per share. The ex-dividend date of this dividend was Friday, August 21st. This represents a $0.80 annualized dividend and a yield of 4.1%. Bath & Body Works’s payout ratio is 20.83%.

Analyst Ratings Changes

Several equities analysts have recently weighed in on BBWI shares. Jefferies Financial Group lifted their price objective on Bath & Body Works from $22.00 to $23.00 and gave the company a “hold” rating in a report on Tuesday, July 28th. Citigroup upgraded shares of Bath & Body Works from a “neutral” rating to a “buy” rating and set a $25.00 target price on the stock in a report on Tuesday, August 18th. Robert W. Baird cut their price target on shares of Bath & Body Works from $25.00 to $23.00 and set a “neutral” rating on the stock in a research note on Thursday, August 27th. Piper Sandler began coverage on shares of Bath & Body Works in a report on Friday, May 15th. They issued a “neutral” rating and a $20.00 price target for the company. Finally, TD Cowen increased their price objective on shares of Bath & Body Works from $20.00 to $25.00 and gave the stock a “buy” rating in a research report on Thursday, May 28th. Four equities research analysts have rated the stock with a Buy rating, thirteen have issued a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, the company has a consensus rating of “Hold” and an average price target of $22.29.

Bath & Body Works Profile

Bath & Body Works, Inc is a leading specialty retailer focused on personal care, home fragrance and complementary products. Through its flagship Bath & Body Works brand, the company offers a diverse assortment of shower gels, lotions, fragrance mists, candles and home fragrance items. Its product portfolio also includes the White Barn Candle Co range of premium scented candles and diffusers. Bath & Body Works serves consumers through a combination of brick-and-mortar stores and e-commerce platforms, delivering seasonal collections, limited-edition releases and signature scent lines.

Founded in 1990 as part of Limited Brands (now L Brands), Bath & Body Works opened its first store in New Albany, Ohio, and quickly expanded across the United States.